Thrivent Financial for Lutherans’s iTeos Therapeutics ITOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$563K Buy
56,556
+7,411
+15% +$73.8K ﹤0.01% 2090
2025
Q1
$293K Buy
+49,145
New +$293K ﹤0.01% 2240
2023
Q4
Sell
-24,223
Closed -$265K 2517
2023
Q3
$265K Buy
24,223
+616
+3% +$6.74K ﹤0.01% 2330
2023
Q2
$313K Sell
23,607
-719
-3% -$9.53K ﹤0.01% 2322
2023
Q1
$331K Sell
24,326
-853
-3% -$11.6K ﹤0.01% 2269
2022
Q4
$492K Sell
25,179
-195
-0.8% -$3.81K ﹤0.01% 2125
2022
Q3
$483K Buy
25,374
+5,471
+27% +$104K ﹤0.01% 2086
2022
Q2
$410K Buy
19,903
+3,535
+22% +$72.8K ﹤0.01% 2164
2022
Q1
$527K Buy
+16,368
New +$527K ﹤0.01% 2166